Items where authors include "Richman, S.D."

Article

Woolley, C.E. orcid.org/0000-0002-0770-6968, Domingo, E. orcid.org/0000-0003-4390-8767, Fernandez-Tajes, J. orcid.org/0000-0003-1515-2421 et al. (8 more authors) (2025) Co-evolution of atypical BRAF and KRAS mutations in colorectal tumorigenesis. Molecular Cancer Research. ISSN 1541-7786

Williams, C.J.M. orcid.org/0000-0002-1574-653X, Gray, R., Hills, R.K. et al. (22 more authors) (2024) Evaluation of CD3 and CD8 T-Cell Immunohistochemistry for Prognostication and Prediction of Benefit From Adjuvant Chemotherapy in Early-Stage Colorectal Cancer Within the QUASAR Trial. Journal of Clinical Oncology, 42 (29). pp. 3430-3442. ISSN 0732-183X

Srihar, K., Gusnanto, A., Richman, S.D. et al. (16 more authors) (2024) The ATOM-Seq sequence capture panel can accurately predict microsatellite instability status in formalin-fixed tumour samples, alongside routine gene mutation testing. Scientific Reports, 14. 21870. ISSN 2045-2322

Mahmood, U. orcid.org/0000-0002-2926-3205, Blake, A. orcid.org/0000-0002-8154-6253, Rathee, S. orcid.org/0000-0002-2853-0842 et al. (18 more authors) (2024) Stratification to Neoadjuvant Radiotherapy in Rectal Cancer by Regimen and Transcriptional Signatures. Cancer Research Communications, 4 (7). pp. 1765-1776. ISSN 2767-9764

Lafarge, M.W. orcid.org/0000-0001-9235-783X, Domingo, E. orcid.org/0000-0003-4390-8767, Sirinukunwattana, K. et al. (17 more authors) (2024) Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy. npj Precision Oncology, 8. 89. ISSN 2397-768X

Malla, S.B. orcid.org/0000-0001-5862-3815, Byrne, R.M. orcid.org/0000-0001-6505-6345, Lafarge, M.W. et al. (40 more authors) (2024) Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer. Nature Genetics, 56. pp. 458-472. ISSN 1061-4036

Williams, C.J.M. orcid.org/0000-0002-1574-653X, Elliott, F. orcid.org/0000-0002-3239-6914, Sapanara, N. orcid.org/0009-0005-0994-837X et al. (51 more authors) (2023) Associations between AI-assisted tumor amphiregulin and epiregulin IHC and outcomes from anti-EGFR therapy in the routine management of metastatic colorectal cancer. Clinical Cancer Research, 29 (20). pp. 4153-4165. ISSN 1078-0432

Williams, C.J.M. orcid.org/0000-0002-1574-653X, Elliott, F. orcid.org/0000-0002-3239-6914, Sapanara, N. orcid.org/0009-0005-0994-837X et al. (51 more authors) (2023) Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer. Clinical Cancer Research, 29 (20). pp. 4153-4165. ISSN 1078-0432

Wagner, S.J., Reisenbüchler, D., West, N.P. et al. (46 more authors) (2023) Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study. Cancer Cell, 41. ISSN 1535-6108

Williams, C.J.M. orcid.org/0000-0002-1574-653X, Seligmann, J.F. orcid.org/0000-0003-4379-6005, Elliott, F. et al. (24 more authors) (2021) Artificial Intelligence–Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in RAS Wild-Type Metastatic Colorectal Cancer. Clinical Cancer Research, 27 (12). pp. 3422-3431. ISSN 1078-0432

Proceedings Paper

Williams, C.J.M., Elliott, F., Shires, M. et al. (58 more authors) (2023) Association between artificial intelligence- (AI) assisted tumour AREG and EREG immunohistochemistry (IHC) and outcomes from anti-EGFR therapy during the routine management of metastatic colorectal cancer (mCRC): an observational cohort study. In: The Journal of Pathology. 5th Joint Meeting with the Royal Society of Medicine, 214th Scientific Meeting of the Pathological Society of Great Britain & Ireland, 23 Jan - 02 Feb 2023, London, UK. Wiley , S16-S16.

Williams, C. orcid.org/0000-0002-1574-653X, Gray, R.G., Shires, M. et al. (17 more authors) (2023) Artificial intelligence-assisted evaluation of tumor infiltrating CD3+ and CD8+ T cells for prognostication and prediction of benefit from adjuvant chemotherapy in early stage colorectal cancer (CRC): A retrospective analysis of the QUASAR trial. In: Journal of Clinical Oncology. 2023 ASCO Gastrointestinal Cancers Symposium, 19-21 Jan 2023, San Francisco, USA. American Society of Clinical Oncology , p. 204.

Hassanieh, S., Domingo, E., Blake, A. et al. (16 more authors) (2022) 337P Prediction of poor response to oxaliplatin by an RNA signature derived and validated in colorectal cancer clinical trials. In: Annals of Oncology. ESMO Congress 2022, 09-13 Sep 2022, Paris, France. Elsevier , S691.